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Congenital heart disease (CHD) is one of the most common live birth defects. The 
study of its underlying molecular and genetic mechanisms is crucial to our understanding 
of the origin of CHD and to the improvement of existing treatments. Previous studies have 
shown the importance of the Sonic Hedgehog (Shh) signaling pathway, among others, in 
the embryonic development of heart. Shh from distinct pulmonary and pharyngeal 
endoderm modulates second heart field (SHF) development and atrial septation. We 
provided evidence that the pharyngeal ectoderm may be another source of the Hedgehog 
signal. The conditional knockout of Shh and its paralog, Indian Hedgehog (Ihh), led to 
hypoplastic hearts missing the right ventricle and part of the outflow tract in embryonic 
day 9.5 mice. We used mouse embryonic stem cells (mESCs) to study how Hedgehog 
signaling controls the proliferation of SHF cardiac progenitor cells (CPCs), a potential 
contributing factor to the hypoplastic heart. By treating SHF CPCs with Hedgehog agonist 
and antagonist, we observed that Hedgehog activation increased proliferation within 24 
hours after treatment while Hedgehog inhibition had the opposite effect. Furthermore, the 
heart phenotypes observed in Shh mutants are similar to those observed in mice that 
model Down syndrome (here, “Down syndrome mice). Disruption of Shh signaling in 
Down syndrome mice resulted in increased frequencies of complete atrioventricular 
septal defect (AVSD) in which the dorsal mesenchymal protrusion was absent. Further, 
we examined the interactions between Hedgehog signaling and trisomy in DS mice and 
identified two genes orthologous to chromosome 21, Ripk4 and Grik1, that were 
misregulated beyond the expected 50% increase in expression level. In mESC, we found 
that Grik1 overexpression was correlated with downregulation of Ptch1, a Hedgehog 
 iii 
pathway gene, at the cardiomyocyte stage. The activation of Hedgehog signaling 
suppressed Grik1 transcriptional expression. The knockdown of Hedgehog pathway 
genes Gli1 and Gli2 resulted in normal the Grik1 level back control level. This indicates a 
potential regulatory interaction between Hedgehog signaling and trisomy for Grik1. 
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The primary function of heart is pumping oxygen- and nutrient-rich blood to 
maintain the functionalities of body. Its development requires precise spatial-temporal 
regulation to avoid structural and functional abnormalities. Congenital heart disease (CHD) 
is one of the most common developmental conditions [1], observed in 0.4% to 5% of live 
births [2]. The study of CHD and underlying molecular and genetic mechanisms is crucial 
to our understanding of the origin of CHD and to the improvement of existing treatments. 
Previous studies have shown the importance of Hedgehog signaling [3], especially 
Shh, in the embryonic development of heart. Hedgehog signaling interacts with several 
cardiogenic transcriptional factors such as Gata4 [4], Tbx5 [5], Foxf [6,7], and Bmp [8] to 
modulate SHF development and atrial septation. Hedgehog signaling from distinct 
pulmonary and pharyngeal endoderm is required for inflow and outflow septation, 
respectively [9]. The Shh signaling is required within the dorsal mesocardium for its 
contribution to the atria; severe septal defects occur if Shh signaling is disrupted [10]. The 
loss of Shh also results in outflow tract (OFT) defects.  
Mammals have three Hedgehog homologs, Sonic (Shh), Indian (Ihh) and Desert 
(Dhh), of which Shh is the best studied.  Canonical Shh signaling is activated when the 
Shh molecule binds and inactivates the transmembrane receptor protein, Patched 1 
(Ptch1), located on the target cell. Without the presence of the ligand Shh, Ptch1 
suppresses the activity of another transmembrane protein, Smoothened (Smo). Ptch1 
inhibition of Smo is abolished in response to Shh signaling. Then Ptch1 is internalized 
and degraded, which allows Smo to accumulate and activate downstream signaling 
cascade. This signaling cascade results in the translocation of Gli family proteins (Gli1, 
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Gli2 and Gli3) to the nucleus to initiate the transcription of target genes, such as Ptch1. 
The Gli family proteins are differentially regulated by Shh signaling [11]. Whereas Gli1 
acts as an activator exclusively, Gli2 and Gli3 can switch between activator and repressor 
forms by proteolytic cleavage. Gli2 functions primarily as an activator and Gli3 
predominantly acts as a repressor. Due to the complex processing nature of Gli2 and Gli3, 
Ptch1 and Gli1 are usually used as the direct indicators of Hedgehog signaling.  
Our lab previously showed that the second pharyngeal arch (PA2) potentially 
provides a niche environment that controls the expansion of second heart field (SHF) 
cardiac progenitor cells (CPCs) that express the biomarker, Isl1 (Isl1+ CPCs) [26]. We 
examined the specific signaling pathway that governs the proliferation SHF CPCs in PA2 
(data unpublished). Using transcriptional analysis and X-gal staining, we found Hedgehog 
signaling was highly active in PA2 and not in outflow tract (OFT) or the heart. The 
proliferation of mouse embryonic stem cell-derived CPCs (mESC-CPCs) that were 
cultured on PA2 feeder cells decreased significantly in responses to Hedgehog inhibition.  
Therefore, we hypothesized that Hedgehog signaling within PA2 regulates expansion of 
SHF CPCs.  
In this study, we used both a mouse model and a newly developed mESC line to 
investigate whether our initial hypothesis is true. The mouse model contained an Ap2-
alpha-Cre [12,13] driver that extensively labels the ectodermal region of PA2. The 
conditional knockout of both Shh and Ihh resulted in hypoplastic hearts on embryonic day 
9.5. This result led us to plan experiments to determine whether the hypoplastic heart 
development was caused by defects of proliferation, migration, or differentiation (or a 
combination of these). [These experiments await reopening of the laboratory after the 
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COVID-19 pandemic]. For in vitro experiments, we used the mESCs reporter line, Tbx1 
RFP; Hcn4 GFP to test the responses of SHF-derived cardiomyocytes to Hedgehog 
activation or inhibition. We observed that Hedgehog activation promoted the proliferation 





















Materials and Methods: 
Mice Crosses and Genetics: 
AP2-alphaCre; Shhfl/fl; Ihhfl/fl mice were generated by crossing an AP2-alphaCre; 
Shhfl/+; Ihhfl/+ male mouse with Shhfl/fl; Ihhfl/fl female mice. We previously linage traced AP2-
alpha with ROSA-YFP, which labeled the pharyngeal ectoderm but not the foregut 
endoderm that has been reported to be the source of Hedgehog signaling. With the Cre-
loxP system, we use the AP2-alpha driver to delete the expression of Shh and Ihh at the 
ectodermal region in second pharyngeal arch. Embryos were harvested at Embryonic 
Day 9.5 (E9.5). Theses mice were provided by Dr. Chulan Kwon of Johns Hopkins 
University, School of Medicine. For adult mice, 0.5 mm tail snips were obtained from 3-
week-old mice. For embryos, yolk sacs were used instead. DNA was extracted by using 
Phire Animal Tissue Direct PCR Kit (ThermoFisher Scientific), followed by Polymerase 
Chain Reaction (PCR). Nuclease-free water, Promega GoTaq Green Master Mix, and 
primers designed by Dr. Brian Gibbs (supplied by Integrated DNA Technologies) were 
combined with the extracted DNA for PCR. The samples were then run on an Agarose 
gel (Shh, 2.5%; Ihh and Cre, 2.0%) with ethidium bromide for 30 minutes at 200 volts, 
which were imaged using ultraviolet imaging. 
 
ES Cell Culture and Differentiation: 
Embryonic stem cells (ESCs) line Tbx1-RFP; Hcn4-GFP was maintained in 
standard ESC culture 2i medium composed of GMEM, Leukemia Inducible Factor, Fetal 
Bovine Serum, Glutamax, Non-Essential Amino Acids, beta-Mercaptoethanol, and 
inhibitors PD and Chir. Cells were plated in a gelatinized 6-well plate or flasks and were 
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passaged until they reach 70%-80% confluency. Differentiation was initiated by switching 
from 2i media to Lif media, which are similar to 2i except that the extra Leukemia Inducible 
Factor and the two inhibitors were not included. Twenty-four hours later, Lif media were 
removed and washed cells were trypsinized for 3 minutes for dissociation. The 
dissociated cells were collected, centrifuged at 1100 rpm for 3 minutes, and resuspended 
in 10 mL of SFD +/+ media, which composed of IMDM, Ham’s F12, N2 supplement, B27 
supplement, 10% BSA in PBS, Glutamine, PenStrep, ascorbic acid, and 1-Thioglycerol. 
On Day 0, resuspended cells were seeded into AggreWell 400 (STEMCELL technologies), 
which was pre-coated with Anti-Adherence Rinsing Solution (STEMCELL technologies), 
to form embryoid bodies (EBs). After two-day culture, the EBs were transferred to culture 
plates with the treatment of Chir and Bmp4 on Day3 and Day 4 respectively. EBs were 
then replated in low-attachment plate or flask and sorted by SH800 sorter (Sony 
Biotechnology, Japan) on Day 5.5 or 6. Sorted RFP cells were plated in Nunc 384-well 
Clear Polystyrene Plates and treated with Smoothened Agonist (SAG, Tocris Bioscience), 
Cyclopamine (Selleckchem), and Recombinant Mouse Sonic Hedgehog (mShh, R&D 
Systems). 
 
EdU Labeling, Immunochemistry, and Microscopy: 
For EdU labeling, 10 mM EdU was injected intraperitoneally at 0.075 mg per gram 
bodyweight to pregnant mice at E9.0. Embryos were harvested immediately at 2 hours 
post injection. Upon collection, embryos were fixed in 4% paraformaldehyde in PBS for 
40 minutes, and then transferred to 30% sucrose in PBS overnight. On the other day, 
embryo images were taken by an Axiocam microscope camera. Then they were 
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embedded in O.C.T. Compound (Fisher HealthCare) and flash frozen in a bath of 2-
methyl-butanol with dry ice. The embryos were sectioned and stained using standard 
protocols. Antibodies used were goat Nkx2.5 (1:200; Santa Cruz Biotechnology) with 
Alexa 568 donkey anti-goat secondary antibody (1:500), mouse Troponin T (1:500; 
ThermoFisher Scientific) with Alexa 488 anti-mouse secondary antibody (1:500), rabbit 
Tbx5(1:250; Millipore Sigma) with Alexa 647 anti-rabbit secondary antibody (1:500), 
rabbit anti-phospho-Histone H3 (1:1000; Millipore Sigma) with Alexa 594 anti-mouse 




RLT Lysis buffer from QIAGEN was added to washed cells in cell culture plate. 
The RNA extraction and isolation followed the protocol of RNeasy Micro Kit from QIAGEN. 
The concentration of RNA was determined using a Nanodrop Spectrophotometer. Five 
hundred nanograms of produced cDNA using RT-PCR kit (ThermoFisher Scientific) of 
each sample were used for qPCR analysis. 
 
siRNA, Constructs, and Transfection: 
For Gli1 and Gli2 knockdown, mouse DsiRNA Gli1 (mm.Ri.Gli1.13.1, Integrated 
DNA Technologies) and mouse DsiRNA Gli2 (mm.Ri.Gli2.13.1, Integrated DNA 
Technologies) were used to transfect mESC tGFP cell line with Lipofectamine RNAiMAX 
kit (ThermoFisher Scientific). For Ripk4 and Grik1 overexpression, we used the plasmids 
designed and provided by Anna Moyer from Dr. Roger Reeves’s lab and transfected 
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mESC tGFP cell line on differentiation day 4 with Lipofectamine 3000 (Life Technologies) 
























Double knock-out of Shh and Ihh in PA2 leads to hypoplastic heart at E9.5 
We previously linage-traced AP2-alpha+ cells with AP2-alpha-Cre; ROSA-YFP 
mice, which labeled the pharyngeal ectoderm (unpublished data not shown here) but not 
the foregut endoderm that has been reported to be the source of Hedgehog signaling 
earlier [9]. With the Cre-loxP system, we utilized the AP2-alpha driver to delete the 
expression of Shh and Ihh at the ectodermal region in PA2 to determine the effects of 
Hedgehog signals on the heart formation during the early stages. We crossed Ap2-Cre; 
Shhfl/+; Ihhfl/+ with Shhfl/fl; Ihhfl/fl (Fig.1A) and harvested the embryos at Embryonic Day 9.5 
(E9.5). Wildtype (WT) embryos, which were Ap2-Cre; Shhfl/+; Ihhfl/+, showed normal 
developing pharyngeal arches and heart (Fig.1B, 1B’) with intact OFT, right ventricle (RV) 
and left ventricle (LV). No structural defects of heart or pharyngeal arches were observed 
in the E9.5 embryos of Ap2-Cre; Shhfl/fl; Ihhfl/+ (Fig.1C, 1C’), single knockout of Shh. The 
pharyngeal arches and RV were absent in Ap2-Cre; Shhfl/fl; Ihhfl/fl double knockout (DKO) 
embryos (Fig.1D,1D’). The DKO embryos also displayed slight developmental 
deformation, such as smaller total embryo size. The embryos were cryo-sectioned and 
immunostained with Nkx2.5, a marker of SHF, cTnT, a marker of myocardial tissue, and 
Tbx5 that specifically expressed in the first heart field (FHF). The immunostaining results 
further confirmed that Shh/Ihh DKO causes single chamber formation with disappeared 




Deficiency of hedgehog activity diminishes proliferation of cardiac progenitor cells in the 
SHF 
The next question to be answered is if the absence of RV and part of OT observed 
in Shh/Ihh DKO mouse was due to differential proliferation, apoptosis, or migration of SHF 
CPCs. To determine if proliferation is responsible for the loss of RV in the mutant, we plan 
to perform EdU pulse-tracing experiment [26]. The EdU is a proliferation assay that could 
be directly used to quantitate new synthesized DNA through detecting the fluorescent tag 
attached to deoxyribonucleoside analog. On E9.0, 10 mM EdU is going to be injected 
intraperitoneally at 0.075 mg per gram bodyweight to pregnant mice. After 2, 4, and 8 
hours post-EdU injection, embryos are harvested for EdU detection followed by 
immunostaining with SHF progenitor marker Isl1, cardiac troponin (cTnT), cell mitosis 
marker phosphor-histone H3 (PH3), and DAPI. If the percentage of triple-positive (Isl1+, 
PH3+, EdU+) cells in Isl1+ cells within PA2 in the DKO mutant is significantly smaller than 
that of wild-type embryo at the same time point, the proliferation of CPC in PA2 diminished 
by the lack of Hedgehog signals.  
To examine if migration is influenced by Hedgehog DKO, we plan to perform a dual 
injection experiment in which both EdU and BrdU are going to be sequentially injected at 
a 4-hr interval. The BrdU assay is another type of proliferation assay that requires DNA 
denaturation. Four hours post-BrdU injection or 8 hours post-EdU injection, embryos are 
harvested, fixed, and sectioned for EdU and BrdU detection. The sections are co-stained 
with Isl1 and DAPI. In wildtype, EdU+ progeny should proliferate and migrate out of PA2 
(Isl1+ region) while BrdU+ progeny remains within PA2. If no migration of EdU+ progeny 
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observed and EdU+ region doesn’t extend beyond the BrdU+ region in the DKO mutant, 
then the movement of CPC is restricted to PA2. 
All the above speculative observations assume only proliferation or migration is 
affected at one time. If both of them are perturbed by the deficiency of Hedgehog signals, 
the observation will be much more complicated and further experiments may be required. 
 
Hedgehog signaling affects the expansion of SHF CPCs-derived cardiomyocyte 
To determine if Hh signaling plays a role in the expansion of SHF CPCs, mESCs 
were differentiated to CPCs (Fig.3A) and sorted for RFP+, Tbx1+cells (Fig.3A), i.e., SHF 
CPCs. Cells seeded on gelatin-coated plates were treated with Smoothened agonist 
(SAG, Hh activator) and Cyclopamine (Hh inhibitor) for 24 hours. The capability of SAG 
to activate the Hh signaling pathway was confirmed using qPCR to demonstrate 
increased transcription of Gli1 and Ptch1 after treatment (Fig.4A-B). Treatment with 125 
𝜇𝑀 SAG increased Gli1 expression by 51.5-fold and 250 𝜇𝑀of SAG increased it by 88.0 
folds. The average numbers of cardiomyocytes (stretched, triangular-shaped cells) of 125 
𝜇𝑀  SAG and 250 𝜇𝑀 of SAG counted in 10X fields (Fig.3B) were 163 and 183, 
respectively. As we expected, activation of Hedgehog signaling by SAG prompted the 
proliferation of RFP+ SHF cardiomyocytes compared to control (Fig.3C). The suppression 
of Hedgehog signaling by the Smo antagonist, Cyclopamine, was also verified as Gli1 
expression decreased by 71% and 46% of that in control in responses to 1 𝜇𝑀 and 10 
𝜇𝑀	 treatments, respectively. That contradicts to our expectation that the extent of 
suppression is positively correlated to the dosage of Cyclopamine. The declines in cell 
number of 1 𝜇𝑀 and 10 𝜇𝑀 Cyclopamine treatment groups relative to control were not as 
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dramatic as that of group with treatment of both SAG and Cyclopmaine (Fig.3C). The 
possible explanation was that the re-plated cells on gelatin-coated surface lacked a 
source of Hedgehog molecules. The signaling was at baseline level and not fully activated 
causing changes were hard to be observed. It may also be caused by technical failures. 
All we can conclude from those preliminary results is that the activation of Hedgehog 
promotes the expansion of mESCs SHF-derived cardiomyocytes.  
For future experiment, we need to optimize the dosage of Cyclopamine to see if 
the proliferation rate of mESCs SHF-derived cardiomyocytes is negatively correlated with 
its concentration as observed here. Except to cell count, we need also perform EdU 
staining as well as PH3 staining to examine how Hedgehog signals influence the 
proliferation of mESCs SHF-derived cardiomyocytes at cell cycle level. Since mESC-
system is sensitive to time, we plan to culture mESCs SHF-derived cardiomyocytes in 
SAG/Cyclopamine-treated media longer to see if the cell responses vary with time. 
 
Grik1 overexpression suppress Hedgehog signaling mRNA expression in SHF derived 
cardiomyocytes 
Down syndrome (DS) is caused by inheritance of three copies of human 
chromosome 21. The prevalence of CHD in infants with DS is about 40%, which is over 
133 times higher than in normal children [14], and AVSD is one of the typical 
malformations. The atrioventricular septum is formed by the fusion of atrial septum, dorsal 
mesenchymal protrusion (DMP), and endocardial cushion [15]. Recent evidence 
indicates that DMP malformation is the contributing factor to AVSD [16,17,18]. In mice 
with reduced Shh signaling, similar heart phenotypes were observed to those in Trisomy 
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mouse models [19,20,21]. Besides, DMP is hypoplastic or absent if Shh signaling is 
disrupted in DMP progenitors or in the SHF [9]. Shh signaling may play an important role 
in formation of the DMP as deletion of the Shh pathway activator, Smo, from the SHF 
resulted in compromised DMP formation and AVSD [22]. As an extension of this thesis 
project, we also examined how Shh signaling interacted with identified risk genes found 
in DS. 
In our collaborative project with Dr. Roger Reeves’s lab, we studied molecular and 
genetic mechanisms underlying high AVSD penetrance in DS. We performed RNA-
sequencing analysis using cells collected from posterior SHF from E9.5 mouse embryos 
of Isl-Cre; Dp16; Smofl/fl, a new mouse model with 100% AVSD we recently developed. 
Our unpublished data showed that both Ripk4 and Grik1 were among the most 
differentially expressed genes in Isl1+ SHF cells. This is in accordance with Dr. 
Antonarakis’s study in which his group identified two CHD risk alleles on chromosome 21 
in patients with Down Syndrome (DS): Ripk4 and Grik1 [23]. 
To mimic the high expression level of Ripk4 and Grik1 caused by trisomy21, we 
overexpressed both of them using transfecting tGFP cell line, a non-DS mESC cell line, 
with plasmids provided by Dr. Roger Reeves’s lab. The GFP+ cells were FACS sorted 
and cultured on gelatin-coated plates for 24, 48 and 72 hours and then harvested for 
qPCR analysis (Fig. 5A). To examine the independent and combinational effects of Ripk4 
and Grik1 on the Hedgehog signaling pathway, we designed 7 conditions: three control 
conditions including the baseline control, 100 nM SAG-treated control, and 100 nM SAG 
plus 10 𝜇 M Cyclopamine-treated control, Ripk4 overexpression (OE), Grik1 OE, 
Ripk4+Grik1 OE and Ripk4+Grik1 OE with Cyclopamine treatment (Table 1). The cells 
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were at cardiac progenitor stage 24 hours after treatment and entered the cardiomyocyte 
stage after 72 hours. Overexpression of Ripk4 and Grik1 was confirmed by qPCR (Fig.5 
B-C). Within 24 hours, Hedgehog pathway genes Ptch1, Gli1, Gli2 and Gli3, were not 
differentially expressed in any conditions compared to control in response to Ripk4/Grik1 
OE. However, Grik1 overexpression induces significant downregulation of Ptch1 and Gli1, 
whereas Gli2 and Gli3 (Fig.5D-G) were upregulated about 72 hours after treatment. In 
summary, the overexpression of Grik1 induced downregulation of Hedgehog signaling 
pathway. This result indicated that Grik1 may be an important regulator of Hedgehog 
signaling in individuals with DS, which is a potential mechanism that causes increased 
AVSD penetrance among DS patient compared to normal people. 
 
Hedgehog activation causes downregulation of Grik1 and Gli2 knockdown recover Grik1 
expression in SHF-derived cardiomyocytes 
Next, we were interested to see if the Ripk4/Grik1 and Hedgehog mutually regulate 
each other. To determine that, we used siRNA to knockdown Gli1 and Gli2, major 
effectors of the canonical Hedgehog signaling cascade, and performed qPCR at 24, 48 
and 72 hours after transfection to test the expression of Ripk4 and Grik1.All reactions 
were treated with SAG except baseline control (Table 2) because the dissociated cells in 
plates didn’t have a source of Hedgehog signals as they do in vivo. It would be hard to 
observe changes in expression if the Hedgehog pathway was not activated. Similar to the 
Ripk4/Grik1 OE experiment, we didn’t see any significant changes within 24 and 48 hours. 
When cells became cardiomyocytes (72 hours), interaction regulation of Hedgehog 
signaling on Grik1 was observed. The knockdown of Gli1 was successful as both Gli1 
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and Ptch1, two direct readouts of the Hedgehog pathway, were greatly suppressed (Fig.6 
A and C). Although the Gli2 expression level didn’t reduce in response to either Gli1 or 
Gli2 KD (Fig.6B), the Gli1 expression level went down (Fig.6A). No changes in the Ripk4 
level were observed in either Gli1 or Gli2 knockdown conditions. In responses to 
Hedgehog activation by SAG treatment, the Grik1 expression level was greatly reduced 
by 5.71 folds compared to baseline control (Fig.6D). In Gli1 and Gli2 KD, Grik1 expression 
increased by 2.95 folds and 7.51 folds relative to SAG-treated control, respectively 
(Fig.6E). Knockdown of Gli2 brought the Grik1 level back to that of baseline control. Thus, 
manipulation of the Hedgehog signaling pathway is correlated with changes in expression 
of Grik1 but not Ripk4. Combined with our observations in the Grik1 OE experiment, it 















Previous studies have shown that Shh ligands are produced from cells that reside 
in pharyngeal endoderm and pulmonary endoderm, which are necessary for arterial 
septation and outflow tract septation, respectively [24]. Our results here suggest that 
pharyngeal ectoderm may be another source of Hedgehog signaling. The conditional 
knockout of both Shh and Ihh within pharyngeal ectoderm using Ap2-alpha driver led to 
single-chamber hearts on E9.5 in mice. The overall size of mutant embryos was smaller 
than that of wildtype. The right ventricle and part of outflow tract, which are derived in part 
from SHF, were absent in double knockout embryos. Further, pharyngeal arches were 
malformed or absent. Thus, Hedgehog signals from pharyngeal ectoderm played 
important roles in the development of SHF-derived regions. Whether this defect was 
caused by insufficient proliferation, increased apoptosis, both of them and failure in cell 
migration. A next step to determine which of these mechanisms is involved would be to 
perform EdU pulse-tracing experiment for proliferation, dual injection of EdU and BrdU 
for migration and test Caspase expression for apoptosis in sagittal sections of E9.5 
embryos.  
To investigate how the Hedgehog signaling regulate SHF CPC proliferation and 
cell fate, we utilized an in vitro model to manipulate Hedgehog signaling. The proliferation 
rate of SHF CPC-derived cardiomyocytes increased in response to Hedgehog activation 
by SAG within 24 hours, as observed in Fig.3 B&F. The cell counts of cultures treated 
with 125 𝜇𝑀 or 250 𝜇𝑀 SAG group were 1.42-fold and 1.56-fold higher than that of control, 
respectively. However, the cell counts of Cyclopamine-treated cultures didn’t show the 
presumed positive correlation with Cyclopamine dosage. A possible explanation was that 
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replated cells on gelatin-coated surface lacked a source of Hedgehog molecules. Thus, 
the signaling was at baseline level and not fully activated causing changes were hard to 
be observed. It could also be caused by technical failures. Due to the pandemic issue, 
we were not able to replicate the experiments. In results we did what suggested to us is 
that the protocol of Hedgehog inhibition need to be adjusted. All we can conclude from 
those preliminary results is that the stimulation of Hedgehog signaling pathway promotes 
expansion of mESCs SHF-derived cardiomyocytes within 24 hours after treatment. In 
future, we plan to optimize the concentration of SAG and Cyclopamine administrated to 
mESCs SHF-derived cardiomyocytes. To assess how mESCs SHF-derived 
cardiomyocytes react to stimulation and inhibition in the perspective of proliferation at cell 
cycle level, EdU and PH3 staining are required. We need more evidence to support our 
preliminary conclusion.  For all above experiments, we didn’t take account of cell-cell 
interactions between SHF CPCs and the interactions between SHF and FHF populations. 
Instead of isolating SHF cells on Day 6 via FACS sorting, we plan to keep the embryoid 
bodies intact, manipulate the Hedgehog signaling through SAG and Cyclopamine 
treatment, and test how SHF CPCs will response in the perspective of proliferation. 
Hoffmann’s studies [7, 9] showed that early in heart development, Hedgehog-
responsive cells migrate from SHF and contribute to the primary atrial septum, DMP, 
endocardial cushions and pulmonary trunk. The malformation of DMP leads to complete 
AVSD with an incidence rate of 20% in patients with DS. Multiple lines of evidence 
implicate a Shh response deficit in trisomic cells as a contributor to multiple features of 
DS [25]. Therefore, we were interested to determine whether Hedgehog mitogens interact 
with genes on chromosome 21 in human, such as RIPK4 and GRIK1 [23]. In our qPCR 
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analysis, we found Grik1 overexpression caused significant downregulation in Ptch1 and 
Gli1, whereas Gli2 and Gli3 (Fig.5D-G) were upregulated about 72 hours after treatment. 
The activation of Hedgehog suppressed Grik1 expression at transcriptional level (Fig.6E) 
while inhibition of the Hedgehog pathway rescued Grik1 expression back to baseline 
(Fig.6E). Those preliminary results suggest a potential negative regulation loop between 
Grik1 and Hedgehog (Gli1 and Gli2) (Fig.6F). Further experiments are needed to validate 
this hypothesis. We can knockdown Grik1 in mESCs cell line and repeat the same 
analysis as we did for Grik1 overexpression.  
In summary, our results provide evidence that the ectodermal region of the second 
pharyngeal arch in mouse is a potential source of Hedgehog signals that influence the 
development of SHF-derived regions, RV and OFT, probably through controlling the 
proliferation of SHF CPCs. And we reveal a possible regulatory interaction between Grik1 
and Hedgehog pathway genes. It paves a path for our future studies of genetic and 













Table 1: Treatment conditions of Ripk4/Grik1 OE experiment 
 



































Figure 1: Double knock-out of Shh and Ihh in PA2 leads to hypoplastic heart at E9.5 
(A) Scheme for mating strategy to generate Shh and Ihh double knockout embryos. (B-
D) Lateral views of control: Ap2-Cre; Shhfl/+; Ihhfl/+ (B), Ap2-Cre; Shhfl/fl; Ihhfl/+ (Shh KO, 
C), Ap2-Cre; Shhfl/fl; Ihhfl/fl (Shh/Ihh DKO, D) embryos. (B’-D’) Enlargement of boxed 
arears in (B-D), showing normal, normal, hypoplastic PA2 and heart in control (B’), Shh 









Figure 2: Immunostaining of E9.5 mouse embryos with double knock-out of Shh 
and Ihh in PA2. 
(A-C) Cross-sections of control (A), Shh KO (B), and Shh/Ihh DKO (C). Sections stained 
for Nkx2.5 (red), cTnT (green), Tbx5 (white), and DAPI (blue). Pharyngeal arches (red) 
and outflow tract/right ventricle (green) are outlined in dashes. Hd, head; pa, pharyngeal 
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Figure 3: Hedgehog signaling affects the expansion of SHF CPCs-derived 
cardiomyocyte in vitro.  
(A) Workflow of mESCs differentiation. (B) Images of RFP+ SHF cardiac progenitor cells 
24 hours after replating and treatment with SAG, scale bar = 400 𝜇𝑚. Stretched and 
triangular-like cells were cardiomyocytes. (C) Cell count per view square as shown in (B). 

















Figure 4: Expression level of Hedgehog signaling pathway genes under different 
treatment conditions monitored by qPCR.  
(A-C) The transcriptional expression analysis of (A) Gli1, (B) Ptch1, and (C) Smo were 
examined by qPCR. Samples were normalized by Gapdh expression and the control was 
set as 1.0. For each condition, n = 3, paired t-test. Error bars indicate standard error of 
















Figure 5: Interactions between mutant genes (Ripk4 and Grik1) associated with 
high risk of AVSD in DS and Hedgehog signaling pathway.  
(A) Workflow of tGFP mESC line differentiation, transfection and qPCR analysis. (B-C) 
Ripk4 and Grik1 overexpression were validated by qPCR. The data were normalized by 
Gapdh and control was set as 1.0. (D-G) The transcriptional expression levels of 
Hedgehog pathway genes: Ptch1 (D), Gli1 (E), Gli2 (F), and Gli3 (G) were examined by 
qPCR. Samples were normalized by Gapdh expression and the control was set as 1.0. 
For each condition, n = 4, paired t-test. Error bars indicate standard error of mean. 
Asterisks indicate statistical significance at P≤0.05. 
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Figure 6: The activation of Hedgehog signaling induced suppressed Grik1 
expression and Gli1/Gli2 knockdown recovered Grik1 expression level back.  
(A-B) Gli1 and Gli2 knockdown were validated by qPCR. The data were normalized by 
Gapdh and control was set as 1.0. (C-E) The transcriptional expression levels of 
Hedgehog pathway genes: Ptch1 (C), trisomy genes: Ripk4 (D), and Grik1 (E) were 
examined by qPCR. Samples were normalized by Gapdh expression and the control was 
set as 1.0. For each condition, n = 4, paired t-test. Error bars indicate standard error of 
mean. Asterisks indicate statistical significance, P≤0.05. (F) Proposed regulation 
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